Cargando…
Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites asso...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240692/ https://www.ncbi.nlm.nih.gov/pubmed/32244618 http://dx.doi.org/10.3390/sports8040044 |
_version_ | 1783536939462295552 |
---|---|
author | Høeg, Tracy B. Chmiel, Kenneth Warrick, Alexandra E. Taylor, Sandra L. Weiss, Robert H. |
author_facet | Høeg, Tracy B. Chmiel, Kenneth Warrick, Alexandra E. Taylor, Sandra L. Weiss, Robert H. |
author_sort | Høeg, Tracy B. |
collection | PubMed |
description | The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites associated with faster finish times were identified. Based on these results, runners at the 2017 WSER underwent targeted metabolomics testing, including lipidomics and choline levels. The 2017 participants’ plasma metabolites were correlated with finish times and compared with non-athletic controls. In 2016, 427 known molecules were detected using non-targeted metabolomics. Four compounds, all phosphatidylcholines (PCs) were associated with finish time (False Discovery Rate (FDR) < 0.05). All were higher in faster finishers. In 2017, using targeted PC analysis, multiple PCs, measured pre- and post-race, were higher in faster finishers (FDR < 0.05). The majority of PCs was noted to be higher in runners (both pre- and post-race) than in controls (FDR < 0.05). Runners had higher choline levels pre-race compared to controls (p < 0.0001), but choline level did not differ significantly from controls post-race (p = 0.129). Choline levels decreased between the start and the finish of the race (p < 0.0001). Faster finishers had lower choline levels than slower finishers at the race finish (p = 0.028). |
format | Online Article Text |
id | pubmed-7240692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72406922020-06-11 Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance Høeg, Tracy B. Chmiel, Kenneth Warrick, Alexandra E. Taylor, Sandra L. Weiss, Robert H. Sports (Basel) Article The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites associated with faster finish times were identified. Based on these results, runners at the 2017 WSER underwent targeted metabolomics testing, including lipidomics and choline levels. The 2017 participants’ plasma metabolites were correlated with finish times and compared with non-athletic controls. In 2016, 427 known molecules were detected using non-targeted metabolomics. Four compounds, all phosphatidylcholines (PCs) were associated with finish time (False Discovery Rate (FDR) < 0.05). All were higher in faster finishers. In 2017, using targeted PC analysis, multiple PCs, measured pre- and post-race, were higher in faster finishers (FDR < 0.05). The majority of PCs was noted to be higher in runners (both pre- and post-race) than in controls (FDR < 0.05). Runners had higher choline levels pre-race compared to controls (p < 0.0001), but choline level did not differ significantly from controls post-race (p = 0.129). Choline levels decreased between the start and the finish of the race (p < 0.0001). Faster finishers had lower choline levels than slower finishers at the race finish (p = 0.028). MDPI 2020-04-01 /pmc/articles/PMC7240692/ /pubmed/32244618 http://dx.doi.org/10.3390/sports8040044 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Høeg, Tracy B. Chmiel, Kenneth Warrick, Alexandra E. Taylor, Sandra L. Weiss, Robert H. Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title | Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title_full | Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title_fullStr | Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title_full_unstemmed | Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title_short | Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance |
title_sort | ultramarathon plasma metabolomics: phosphatidylcholine levels associated with running performance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240692/ https://www.ncbi.nlm.nih.gov/pubmed/32244618 http://dx.doi.org/10.3390/sports8040044 |
work_keys_str_mv | AT høegtracyb ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance AT chmielkenneth ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance AT warrickalexandrae ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance AT taylorsandral ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance AT weissroberth ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance |